Júlia Albó Delgado

Júlia graduated in Biotechnology from the University of Barcelona in 2021 and obtained an MSc in Advanced Immunology in 2022. She carried out her BSc and MSc thesis in a pre-clinical study of a therapeutic mRNA-based vaccine against HIV infection in IDIBAPS, focusing in PD-L1/PD-1 inhibition. In October 2022 she did an extracurricular internship in the group of immunotherapies and tumour immunology at Charles University (Prague, Czech Republic). 

Currently, she is conducting her PhD under the supervision of Dr. Julià Blanco and Dra. Carmen Aguilar in improving VLPs platform for cancer application.